BioCentury | Aug 12, 2019
Company News

Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

...company to pursue other interests. Ford was SVP, head of global clinical operations, at the Merck Serono...
BioCentury | Feb 22, 2019
Financial News

Merck KGaA spinout Calypso raises first tranche of €20M series A

...each tranche has not been disclosed. In 2013, the company was spun out from the Merck Serono...
BioCentury | Feb 21, 2019
Financial News

Merck KGaA spinout Calypso raises first tranche of €20M series A

...each tranche has not been disclosed. In 2013, the company was spun out from the Merck Serono...
BioCentury | Dec 20, 2018
Company News

Merck KGaA puts CAR T development in Intrexon's hands

...RheoSwitch technology. Under the original terms, Merck would have developed the CAR Ts post-IND (see "Merck Serono...
BioCentury | Mar 23, 2018
Company News

Lundbeck snags PD play Prexton

...Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono S.A. In 2012, Merck Serono's...
BioCentury | Mar 16, 2018
Company News

Lundbeck snags PD play Prexton

...Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono S.A. In 2012, Merck Serono's...
BioCentury | Dec 9, 2017
Strategy

Genmab’s second act

...50% of the costs thereafter. Genmab also had recently regained rights to zanolimumab from the Merck Serono...
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...and develop RNA-targeting therapies against undisclosed targets. In 2013, the fund spun Calypso out of Merck Serono...
BioCentury | Feb 7, 2017
Financial News

Prexton raises EUR 29M in series B round

...Extra, Feb. 6) . Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono...
BioCentury | Jan 5, 2017
Financial News

Financial tracks

...principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono...
Items per page:
1 - 10 of 531
BioCentury | Aug 12, 2019
Company News

Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

...company to pursue other interests. Ford was SVP, head of global clinical operations, at the Merck Serono...
BioCentury | Feb 22, 2019
Financial News

Merck KGaA spinout Calypso raises first tranche of €20M series A

...each tranche has not been disclosed. In 2013, the company was spun out from the Merck Serono...
BioCentury | Feb 21, 2019
Financial News

Merck KGaA spinout Calypso raises first tranche of €20M series A

...each tranche has not been disclosed. In 2013, the company was spun out from the Merck Serono...
BioCentury | Dec 20, 2018
Company News

Merck KGaA puts CAR T development in Intrexon's hands

...RheoSwitch technology. Under the original terms, Merck would have developed the CAR Ts post-IND (see "Merck Serono...
BioCentury | Mar 23, 2018
Company News

Lundbeck snags PD play Prexton

...Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono S.A. In 2012, Merck Serono's...
BioCentury | Mar 16, 2018
Company News

Lundbeck snags PD play Prexton

...Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono S.A. In 2012, Merck Serono's...
BioCentury | Dec 9, 2017
Strategy

Genmab’s second act

...50% of the costs thereafter. Genmab also had recently regained rights to zanolimumab from the Merck Serono...
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...and develop RNA-targeting therapies against undisclosed targets. In 2013, the fund spun Calypso out of Merck Serono...
BioCentury | Feb 7, 2017
Financial News

Prexton raises EUR 29M in series B round

...Extra, Feb. 6) . Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono...
BioCentury | Jan 5, 2017
Financial News

Financial tracks

...principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono...
Items per page:
1 - 10 of 531